BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 21834699)

  • 21. Opioid and adjuvant analgesics: compared and contrasted.
    Khan MI; Walsh D; Brito-Dellan N
    Am J Hosp Palliat Care; 2011 Aug; 28(5):378-83. PubMed ID: 21622486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Buprenorphine for neuropathic pain--targeting hyperalgesia.
    Induru RR; Davis MP
    Am J Hosp Palliat Care; 2009 Dec-2010 Jan; 26(6):470-3. PubMed ID: 19666890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antinociceptive effects of delta-opioid agonists in Rhesus monkeys: effects on chemically induced thermal hypersensitivity.
    Brandt MR; Furness MS; Mello NK; Rice KC; Negus SS
    J Pharmacol Exp Ther; 2001 Mar; 296(3):939-46. PubMed ID: 11181927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peripheral antinociceptive effects of mu- and delta-opioid receptor agonists in NOS2 and NOS1 knockout mice during chronic inflammatory pain.
    Leánez S; Hervera A; Pol O
    Eur J Pharmacol; 2009 Jan; 602(1):41-9. PubMed ID: 19041302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. When medications make pain worse: opioid-induced hyperalgesia.
    Martin CM
    Consult Pharm; 2011 Aug; 26(8):530-42. PubMed ID: 21840817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review of the effect of opioid-related side effects on the undertreatment of moderate to severe chronic non-cancer pain: tapentadol, a step toward a solution?
    Candiotti KA; Gitlin MC
    Curr Med Res Opin; 2010 Jul; 26(7):1677-84. PubMed ID: 20465361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Do opioids induce hyperalgesia in humans? An evidence-based structured review.
    Fishbain DA; Cole B; Lewis JE; Gao J; Rosomoff RS
    Pain Med; 2009; 10(5):829-39. PubMed ID: 19594845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute-onset opioid-induced hyperalgesia in a child with juvenile idiopathic arthritis.
    Vijayan V; Moran R; Elder ME; Sukumaran S
    J Clin Rheumatol; 2012 Oct; 18(7):349-51. PubMed ID: 23047535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnesium ions and opioid agonist activity in streptozotocin-induced hyperalgesia.
    Bujalska M; Malinowska E; Makulska-Nowak H; Gumułka SW
    Pharmacology; 2008; 82(3):180-6. PubMed ID: 18701828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multi-mechanistic analgesia for opioid-induced hyperalgesia.
    Raffa RB; Pergolizzi JV
    J Clin Pharm Ther; 2012 Apr; 37(2):125-7. PubMed ID: 21501205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Opioid rotation in the management of chronic pain: where is the evidence?
    Vissers KC; Besse K; Hans G; Devulder J; Morlion B
    Pain Pract; 2010; 10(2):85-93. PubMed ID: 20070552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opioid hyperalgesia and tolerance versus 5-HT1A receptor-mediated inverse tolerance.
    Xu XJ; Colpaert F; Wiesenfeld-Hallin Z
    Trends Pharmacol Sci; 2003 Dec; 24(12):634-9. PubMed ID: 14654304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging drug targets for pain treatment.
    Li JX; Zhang Y
    Eur J Pharmacol; 2012 Apr; 681(1-3):1-5. PubMed ID: 22314220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute pain management in opioid-tolerant patients: a growing challenge.
    Huxtable CA; Roberts LJ; Somogyi AA; MacIntyre PE
    Anaesth Intensive Care; 2011 Sep; 39(5):804-23. PubMed ID: 21970125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term management of chronic pain with transdermal buprenorphine: a multicenter, open-label, follow-up study in patients from three short-term clinical trials.
    Likar R; Kayser H; Sittl R
    Clin Ther; 2006 Jun; 28(6):943-52. PubMed ID: 16860176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opioid-Induced Hyperalgesia: A Diagnostic Dilemma.
    Carullo V; Fitz-James I; Delphin E
    J Pain Palliat Care Pharmacother; 2015; 29(4):378-84. PubMed ID: 26523869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of cyclo-oxygenase inhibitors in attenuating opioid-induced tolerance, hyperalgesia, and dependence.
    Akbari E
    Med Hypotheses; 2012 Jan; 78(1):102-6. PubMed ID: 22047988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved opioid analgesic effect following opioid dose reduction.
    Vorobeychik Y; Chen L; Bush MC; Mao J
    Pain Med; 2008 Sep; 9(6):724-7. PubMed ID: 18816332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opioid-induced hyperalgesia: a review of epidemiology, mechanisms and management.
    Low Y; Clarke CF; Huh BK
    Singapore Med J; 2012 May; 53(5):357-60. PubMed ID: 22584979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are psychoactive substance (opioid)-dependent chronic pain patients hyperalgesic?
    Fishbain DA; Lewis JE; Gao J
    Pain Pract; 2011; 11(4):337-43. PubMed ID: 21199316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.